Anaptysbio Stock Price Prediction
| ANAB Stock | USD 24.10 1.83 8.22% |
Oversold Vs Overbought
32
Oversold | Overbought |
EPS Estimate Next Quarter (1.64) | EPS Estimate Current Year (6.22) | EPS Estimate Next Year (6.69) | Wall Street Target Price 54.3636 | EPS Estimate Current Quarter (1.65) |
Using AnaptysBio hype-based prediction, you can estimate the value of AnaptysBio from the perspective of AnaptysBio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in AnaptysBio to buy its stock at a price that has no basis in reality. In that case, they are not buying AnaptysBio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
AnaptysBio after-hype prediction price | USD 24.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
AnaptysBio |
AnaptysBio After-Hype Price Prediction Density Analysis
As far as predicting the price of AnaptysBio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AnaptysBio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of AnaptysBio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AnaptysBio Estimiated After-Hype Price Volatility
In the context of predicting AnaptysBio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AnaptysBio's historical news coverage. AnaptysBio's after-hype downside and upside margins for the prediction period are 18.92 and 29.52, respectively. We have considered AnaptysBio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AnaptysBio is not too volatile at this time. Analysis and calculation of next after-hype price of AnaptysBio is based on 3 months time horizon.
AnaptysBio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as AnaptysBio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AnaptysBio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AnaptysBio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.51 | 5.35 | 0.12 | 0.12 | 7 Events / Month | 3 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
24.10 | 24.22 | 0.50 |
|
AnaptysBio Hype Timeline
AnaptysBio is presently traded for 24.10. The entity has historical hype elasticity of 0.12, and average elasticity to hype of competition of -0.12. AnaptysBio is forecasted to increase in value after the next headline, with the price projected to jump to 24.22 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.5%, whereas the daily expected return is presently at -0.51%. The volatility of related hype on AnaptysBio is about 2367.26%, with the expected price after the next announcement by competition of 23.98. The company reported the previous year's revenue of 17.16 M. Net Loss for the year was (163.62 M) with loss before overhead, payroll, taxes, and interest of (78.51 M). Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out AnaptysBio Basic Forecasting Models to cross-verify your projections.AnaptysBio Related Hype Analysis
Having access to credible news sources related to AnaptysBio's direct competition is more important than ever and may enhance your ability to predict AnaptysBio's future price movements. Getting to know how AnaptysBio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AnaptysBio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DCPH | Deciphera Pharmaceuticals LLC | 0.00 | 0 per month | 0.00 | (0.15) | 3.27 | (3.25) | 9.66 | |
| CRNX | Crinetics Pharmaceuticals | 1.32 | 9 per month | 2.43 | (0.01) | 3.67 | (3.45) | 16.75 | |
| RYTM | Rhythm Pharmaceuticals | (2.42) | 8 per month | 2.54 | 0.11 | 7.37 | (4.90) | 17.61 | |
| KURA | Kura Oncology | (0.02) | 7 per month | 0.00 | (0.17) | 4.98 | (4.04) | 42.52 | |
| CTMX | CytomX Therapeutics | (0.01) | 10 per month | 0.00 | (0.15) | 5.00 | (5.22) | 20.61 |
AnaptysBio Additional Predictive Modules
Most predictive techniques to examine AnaptysBio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AnaptysBio using various technical indicators. When you analyze AnaptysBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AnaptysBio Predictive Indicators
The successful prediction of AnaptysBio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AnaptysBio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AnaptysBio based on analysis of AnaptysBio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AnaptysBio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AnaptysBio's related companies. | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 50.35 | 145.75 | 153.04 | PTB Ratio | 3.33 | 6.55 | 6.22 |
Story Coverage note for AnaptysBio
The number of cover stories for AnaptysBio depends on current market conditions and AnaptysBio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AnaptysBio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AnaptysBio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
AnaptysBio Short Properties
AnaptysBio's future price predictability will typically decrease when AnaptysBio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AnaptysBio often depends not only on the future outlook of the potential AnaptysBio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AnaptysBio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.9 M | |
| Cash And Short Term Investments | 390.9 M |
Complementary Tools for AnaptysBio Stock analysis
When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |